These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26088121)

  • 1. GABAB Agonists for the Treatment of Alcohol Use Disorder.
    Mirijello A; Caputo F; Vassallo G; Rolland B; Tarli C; Gasbarrini A; Addolorato G
    Curr Pharm Des; 2015; 21(23):3367-72. PubMed ID: 26088121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of GABA
    Maccioni P; Colombo G
    CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
    Augier E
    Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies.
    Farokhnia M; Browning BD; Leggio L
    Curr Opin Psychiatry; 2019 Jul; 32(4):255-265. PubMed ID: 31107292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA
    Logge WB; Morley KC; Haber PS
    Curr Top Behav Neurosci; 2022; 52():195-212. PubMed ID: 33580440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of the [3H] gamma-hydroxybutyric acid (GHB) binding site to the gamma-aminobutyric acidB (GABAB) receptor in rat brain.
    Snead OC
    Biochem Pharmacol; 1996 Oct; 52(8):1235-43. PubMed ID: 8937431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of medications for alcohol-use disorders targeting the GABAB receptor system.
    Agabio R; Maccioni P; Carai MA; Gessa GL; Froestl W; Colombo G
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):113-28. PubMed ID: 22574677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAB receptor trafficking and interacting proteins: targets for the development of highly specific therapeutic strategies to treat neurological disorders?
    Benke D
    Biochem Pharmacol; 2013 Dec; 86(11):1525-30. PubMed ID: 24084431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.
    Sabioni P; Bertram J; Le Foll B
    Curr Pharm Des; 2015; 21(23):3306-10. PubMed ID: 26088120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gambling disorder: a side effect of an off-label prescription of baclofen-literature review.
    Guillou-Landreat M; Victorri Vigneau C; Gerardin M
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28073872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.
    Mathivet P; Bernasconi R; De Barry J; Marescaux C; Bittiger H
    Eur J Pharmacol; 1997 Feb; 321(1):67-75. PubMed ID: 9083788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution therapy for alcoholism: time for a reappraisal?
    Chick J; Nutt DJ
    J Psychopharmacol; 2012 Feb; 26(2):205-12. PubMed ID: 21742726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
    Auffret M; Rolland B; Caous AS; Gaboriau L; Deheul S; Bordet R; Gautier S
    Fundam Clin Pharmacol; 2018 Apr; 32(2):234-238. PubMed ID: 29143356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and side effects of baclofen and the novel GABA
    Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
    Gemignani A; Paudice P; Bonanno G; Raiteri M
    Mol Pharmacol; 1994 Sep; 46(3):558-62. PubMed ID: 7935338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of pre- and postsynaptic GABAB receptors in the deep nuclei of rat cerebellar slices.
    Morishita W; Sastry BR
    Neuroscience; 1995 Oct; 68(4):1127-37. PubMed ID: 8544987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices.
    Parker DA; Ong J; Marino V; Kerr DI
    Eur J Pharmacol; 2004 Jul; 495(2-3):137-43. PubMed ID: 15249162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen-induced edema in alcohol use disorders.
    Bence C; Cottencin O; Deheul S; Gautier S; Bordet R; Rolland B
    J Clin Pharmacol; 2014 Apr; 54(4):478-81. PubMed ID: 24293402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.